State Of Tennessee, Treasury Department Catalent, Inc. Transaction History

State Of Tennessee, Treasury Department

$27.8 Billion
Q3 2024

A detailed history of State Of Tennessee, Treasury Department transactions in Catalent, Inc. stock. As of the latest transaction made, State Of Tennessee, Treasury Department holds 39,519 shares of CTLT stock, worth $2.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

39,519

Previous 64,363 38.6%

Holding current value

$2.41 Million

Previous $3.62 Million 33.88%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$56.16 - $60.96 $1.4 Million - $1.51 Million	-24,844 Reduced 38.6%	39,519 $2.39 Million
Q2 2024 Aug 13, 2024	SELL	$53.58 - $57.02 $1.23 Million - $1.31 Million	-22,990 Reduced 26.32%	64,363 $3.62 Million
Q1 2024 May 14, 2024	BUY	$42.56 - $59.82 $2.55 Million - $3.58 Million	59,809 Added 217.14%	87,353 $4.93 Million
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $15,156 - $21,934	-471 Reduced 1.68%	27,544 $1.24 Million
Q1 2023 May 12, 2023	BUY	$45.44 - $74.26 $41,759 - $68,244	919 Added 3.39%	28,015 $1.84 Million
Q4 2022 Feb 15, 2023	SELL	$41.39 - $81.0 $836,823 - $1.64 Million	-20,218 Reduced 42.73%	27,096 $1.22 Million
Q3 2022 Jan 26, 2023	BUY	$72.36 - $113.1 $128,800 - $201,318	1,780 Added 3.91%	47,314 $3.42 Million
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $1.58 Million - $2.06 Million	18,062 Added 65.75%	45,534 $4.89 Million
Q1 2022 May 11, 2022	SELL	$94.19 - $124.49 $10.7 Million - $14.2 Million	-113,901 Reduced 80.57%	27,472 $3.05 Million
Q4 2021 Feb 15, 2022	SELL	$119.57 - $139.07 $9.35 Million - $10.9 Million	-78,189 Reduced 35.61%	141,373 $18.1 Million
Q3 2021 Nov 12, 2021	SELL	$109.17 - $142.35 $9.15 Million - $11.9 Million	-83,795 Reduced 27.62%	219,562 $29.2 Million
Q2 2021 Aug 11, 2021	BUY	$100.34 - $115.69 $21.1 Million - $24.3 Million	210,073 Added 225.2%	303,357 $32.8 Million
Q1 2021 May 10, 2021	SELL	$101.51 - $125.27 $3.69 Million - $4.55 Million	-36,315 Reduced 28.02%	93,284 $9.82 Million
Q4 2020 Feb 09, 2021	BUY	$85.88 - $105.36 $1.84 Million - $2.26 Million	21,457 Added 19.84%	129,599 $13.5 Million
Q3 2020 Nov 16, 2020	BUY	$72.74 - $92.5 $223,457 - $284,160	3,072 Added 2.92%	108,142 $9.26 Million
Q2 2020 Aug 13, 2020	SELL	$48.02 - $79.04 $362,887 - $597,305	-7,557 Reduced 6.71%	105,070 $7.7 Million
Q1 2020 May 15, 2020	BUY	$36.95 - $62.95 $1.87 Million - $3.18 Million	50,532 Added 81.38%	112,627 $5.85 Million
Q4 2019 Feb 06, 2020	SELL	$47.06 - $56.64 $2.36 Million - $2.85 Million	-50,237 Reduced 44.72%	62,095 $3.5 Million
Q3 2019 Oct 30, 2019	SELL	$47.45 - $58.05 $2.05 Million - $2.51 Million	-43,190 Reduced 27.77%	112,332 $5.35 Million
Q2 2019 Aug 12, 2019	BUY	$39.26 - $54.21 $4.16 Million - $5.74 Million	105,868 Added 213.21%	155,522 $8.43 Million
Q1 2019 May 13, 2019	SELL	$29.84 - $43.92 $1.49 Million - $2.2 Million	-50,000 Reduced 50.17%	49,654 $2.02 Million
Q4 2018 Feb 11, 2019	BUY	$29.95 - $46.34 $59,330 - $91,799	1,981 Added 2.03%	99,654 $3.11 Million
Q3 2018 Nov 13, 2018	SELL	$40.12 - $45.55 $93,359 - $105,994	-2,327 Reduced 2.33%	97,673 $4.45 Million
Q2 2018 Aug 14, 2018	SELL	$38.72 - $42.52 $1.94 Million - $2.13 Million	-50,000 Reduced 33.33%	100,000 $4.19 Million
Q1 2018 May 11, 2018	SELL	$39.4 - $47.39 $2.36 Million - $2.84 Million	-60,000 Reduced 28.57%	150,000 $6.16 Million
Q4 2017 Feb 12, 2018	BUY	$37.27 - $43.02 $3.73 Million - $4.3 Million	100,000 Added 90.91%	210,000 $8.63 Million
Q3 2017 Nov 01, 2017	BUY	$33.75 - $41.67 $3.71 Million - $4.58 Million	110,000	110,000 $4.39 Million

Others Institutions Holding CTLT

# of Institutions

513

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.

Account

State Of Tennessee, Treasury Department Catalent, Inc. Transaction History